- Vision & Strategy
- The Wisdom Agenda
- Research Integrity
- UCL Grand Challenges
- UCL Research Frontiers
- UCL Public Policy
- UCL Research Domains
- Strategic Partnerships
- Access UCL Expertise
- UCL Research Staff Hub
- BEAMS Funding Office
- SLMS Research Coordination Office
- Professor David Price, UCL Vice-Provost (Research)
- REF2014 results: read analysis by the UCL Vice-Provost (Research)
UCL staff may subscribe to the UCL OVPR newsletter.
A drug which is used to treat the common eye disease glaucoma may have potential as a treatment for Alzheimer’s disease, according to scientists at UCL. More...
Published: Dec 8, 2016 2:14:29 PM
The number of mothers passing the HIV virus to their babies has fallen to a new record low in the UK and Ireland thanks to the very high take-up of antenatal HIV screening and treatment which reduces virus levels in the pregnant women, according to research led by UCL. More...
Published: Dec 8, 2016 10:34:57 AM
Women with dementia have fewer visits to the GP, receive less health monitoring and take more potentially harmful medication than men with dementia, new UCL research reveals. More...
Published: Dec 5, 2016 11:55:26 AM
A new battlefront is opening in science denialism and this time the target is the science of invasive alien species and the fight to protect some of the world’s rarest species and most unique ecosystems, say a team involving UCL scientists. More...
Published: Dec 2, 2016 1:03:39 PM
Significant numbers of patients whose HIV strains developed resistance to older generation drugs are also resistant to modern drugs, finds a new study led by UCL and funded by Wellcome. More...
Published: Dec 1, 2016 10:21:57 AM
Page last modified on 18 apr 16 09:32